Pacira BioSciences Ownership | Who Owns Pacira BioSciences?


OverviewForecastRevenueFinancialsChartTranscripts

Pacira BioSciences Ownership Summary


Pacira BioSciences is owned by 53.31% institutional investors, 1.89% insiders, and 44.80% retail investors. Blackrock is the largest institutional shareholder, holding 17.34% of PCRX shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 6.13% of its assets in Pacira BioSciences shares.

PCRX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockPacira BioSciences53.31%1.89%44.80%
SectorHealthcare Stocks 42.53%10.81%46.67%
IndustrySpecialty & Generic Drug Manufacturers Stocks26.16%11.89%61.94%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock8.01M17.34%$229.08M
Blackrock funding, inc. /de7.34M16.14%$189.05M
Vanguard group5.20M11.43%$133.94M
Doma perpetual capital management2.70M5.94%$69.61M
D. e. shaw2.26M4.89%$42.53M
Dimensional fund advisors lp2.16M4.76%$55.75M
Renaissance2.14M4.70%$55.10M
Balyasny asset management2.13M4.69%$50.92M
State street1.90M4.18%$48.98M
American century companies1.38M3.03%$35.52M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Doma perpetual capital management2.70M23.38%$69.61M
Sio capital management455.50K3.53%$13.03M
Gagnon advisors213.40K3.40%$5.50M
Gagnon securities449.72K2.32%$11.59M
Bridge city capital311.44K2.14%$8.03M
Hussman strategic advisors105.00K0.59%$2.71M
Phocas financial146.90K0.49%$3.79M
Easterly investment partners249.11K0.43%$6.42M
J. goldman & co lp669.14K0.43%$17.24M
Diadema partners lp58.93K0.39%$1.52M

Top Buyers

HolderShares% AssetsChange
Doma perpetual capital management2.70M23.38%897.25K
Balyasny asset management2.13M0.08%565.29K
Adage capital partners gp410.00K0.02%410.00K
Sio capital management455.50K3.53%343.50K
Nuveen asset management625.92K0.00%327.75K

Top Sellers

HolderShares% AssetsChange
Frontier capital management---1.84M
Stephens investment management group---1.37M
Clearbridge investments---1.17M
Millennium management345.63K0.00%-1.14M
Point72 asset management---1.08M

New Positions

HolderShares% AssetsChangeValue
Adage capital partners gp410.00K0.02%410.00K$10.57M
Norges bank127.66K0.00%127.66K$2.41M
Axa investment managers117.28K0.01%117.28K$3.02M
Hussman strategic advisors105.00K0.59%105.00K$2.71M
Exchange traded concepts75.60K0.02%75.60K$1.95M

Sold Out

HolderChange
Prairieview partners-5.00
Sjs investment consulting-5.00
Larson financial group-6.00
Dinuzzo private wealth-6.00
Annis gardner whiting capital advisors-8.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 2025127-44.30%24,235,325-47.07%530.53%56-51.30%48-31.43%
Jun 30, 2025233-3.32%50,471,236-0.11%1110.93%114-1.72%75-6.25%
Mar 31, 202510-95.90%2,660,835-94.67%50.05%5-95.65%4-95.00%
Dec 31, 2024121-51.60%26,315,048-48.41%570.47%54-60.00%40-43.66%
Sep 30, 2024249-13.54%51,009,626-1.76%1100.87%137-12.74%70-7.89%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF2.75M6.13%-
Vanguard Total Stock Mkt Idx Inv1.37M3.04%-30.32K
Vanguard US Total Market Shares ETF1.37M2.97%-
Delaware Small Cap Core I1.26M2.74%-18.77K
iShares Russell 2000 ETF1.11M2.47%-
Vanguard Small Cap Index1.07M2.38%-7.22K
Avantis US Small Cap Value ETF975.98K2.17%2.78K
Stephens SMID Select Growth863.32K1.87%-4.92K
Polar Capital Healthcare Opports Inc752.34K1.68%-158.12K
Vanguard Small Cap Value Index Inv688.17K1.53%2.33K

Recent Insider Transactions


DateNameRoleActivityValue
Nov 17, 2025SLONIN JONATHAN Chief Medical OfficerSell$95.40K
Nov 10, 2025Cross Shawn Chief Financial OfficerSell$266.41K
Sep 04, 2025Ceesay Abraham-Sell$64.01K
Aug 07, 2025BIGAL MARCELO-Sell$116.27K
Jun 04, 2025RIKER LAUREN Senior Vice President, FinanceSell$146.21K

Insider Transactions Trends


DateBuySell
2025 Q4-2
2025 Q3-2
2025 Q2-2
2025 Q1-1
2024 Q4-1

PCRX Ownership FAQ


Who Owns Pacira BioSciences?

Pacira BioSciences shareholders are primarily institutional investors at 53.31%, followed by 1.89% insiders and 44.80% retail investors. The average institutional ownership in Pacira BioSciences's industry, Specialty & Generic Drug Manufacturers Stocks, is 26.16%, which Pacira BioSciences exceeds.

Who owns the most shares of Pacira BioSciences?

Pacira BioSciences’s largest shareholders are Blackrock (8.01M shares, 17.34%), Blackrock funding, inc. /de (7.34M shares, 16.14%), and Vanguard group (5.2M shares, 11.43%). Together, they hold 44.91% of Pacira BioSciences’s total shares outstanding.

Does Blackrock own Pacira BioSciences?

Yes, BlackRock owns 17.34% of Pacira BioSciences, totaling 8.01M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 229.08M$. In the last quarter, BlackRock increased its holdings by 101.67K shares, a 1.29% change.

Who is Pacira BioSciences’s biggest shareholder by percentage of total assets invested?

Doma perpetual capital management is Pacira BioSciences’s biggest shareholder by percentage of total assets invested, with 23.38% of its assets in 2.7M Pacira BioSciences shares, valued at 69.61M$.

Who is the top mutual fund holder of Pacira BioSciences shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of Pacira BioSciences shares, with 6.13% of its total shares outstanding invested in 2.75M Pacira BioSciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools